A Korean beauty house built from zero in the UAE — sixteen months of compounding growth, real margins, and a category with no dominant regional leader yet.
Launched November 2024. Every figure below is pulled directly from store data — not projections, not estimates.
Walk through K-Beauty in the GCC and you won't find a single homegrown D2C brand operating at meaningful scale.
Eighteen consecutive months of compounding growth — built entirely in-house, with the store converting better than ever.
Cash is the easiest part of this story to quantify — and the smallest part of what was actually invested.
A minority equity position in a live, profitable, self-funded operating business — as a financial partner, not an operating one. Two investment sizes are offered below, each with a straightforward equity split.
This is a passive, sleeping-partner structure: 100% of capital raised goes directly into the business to fund growth — marketing, inventory, Saudi expansion, and technology. Financial projections in this proposal are built on the Option B (USD 2M) scenario. All figures throughout this proposal are shown in USD with AED equivalents, converted at the UAE's fixed peg of USD 1 = AED 3.6725.
This isn't a pre-revenue idea seeking its first capital — it's an eighteen-month-old, self-funded, profitable brand entering its scale-up phase.
Every number backing this proposal — margins, retention, conversion, channel mix — is pulled directly from live store data, detailed in full in the Store Performance section of this document. Capital raised here is deployed entirely into growth: marketing, Saudi Arabia expansion, inventory, warehousing, and technology.
By 2027, the target is maximum automation across every function that currently depends on manual effort or outside vendors — built in-house, owned outright, with no agency or third-party dependency.
The strategic logic is straightforward: every function built in-house is a function with no agency margin sitting on top of it, no dependency risk if a vendor relationship ends, and full data ownership. This is a direct contributor to the margin expansion targeted through 2029.
Systems and discipline first, then expansion, then scale, then multi-market maturity — each phase compounding on the one before.
All projections below are modelled specifically against the USD 2,000,000 (25%) investment scenario, with capital deployed from 2026 onward.
Built on verified current cost structure, with disciplined, gradual margin expansion — not an overnight jump. Shown from 2027 onward, since deal timing will determine how much of 2026 the investor is actually part of.
| Year | Revenue (AED) | Revenue (USD) | Net Margin | Net Profit (AED) | Net Profit (USD) |
|---|---|---|---|---|---|
| 2027 | 12.0M – 14.0M | 3.27M – 3.81M | ~14.6% | ~1.90M | ~517K |
| 2028 | 18.0M – 20.0M | 4.90M – 5.45M | ~16.5% | ~3.14M | ~855K |
| 2029 | 24.0M – 26.0M | 6.54M – 7.08M | ~17.8% | ~4.45M | ~1.21M |
| Figures shown at the midpoint of each year's revenue range. Net margin expands through opex discipline and gradually tapering marketing spend — COGS, fees, and returns are held flat, with no assumed supplier or pricing gains. 2026 is excluded here since it depends on when the investment closes within the year. | |||||
Net profit is distributed annually, in proportion to equity held, starting the first full year after close. No lock-up on distributions, no discretionary withholding.
At the end of each financial year, audited net profit is distributed to both the founder and the investor in direct proportion to their equity holding — 25% to the investor, 75% to the founder under Option B (or 12.5% / 87.5% under Option A). Distribution begins from the first full financial year after the investment closes — 2026 is excluded here since the deal's closing date within the year is not yet known, and the investor's share of that partial year will be agreed separately at signing. Distribution is annual, not discretionary, and both parties withdraw their share in the same cycle. Should either party wish to reinvest their distribution back into the business instead of withdrawing it, that is handled as a separate, mutually agreed capital contribution — it does not automatically or silently change anyone's equity percentage. Any change to equity ownership only happens through a formal, documented agreement between both parties.
Annual profit share is real cash — but it isn't the reason to take this deal. The investor owns a growing percentage of a business whose enterprise value is expected to compound as the business matures, expands into new markets, and builds a physical retail presence.
This is the core of the offer: the investor isn't just buying a slice of annual profit, they're buying a growing stake in a business whose estimated value compounds at roughly 62% per year through 2029 as it de-risks through scale. These are forward-looking estimates, not a current valuation of the business today — actual outcomes will depend on execution. Profit distributions provide interim liquidity along the way; the equity stake is where the larger return potential lives.
A partnership built on trust still benefits from clear, written protections for both sides.
MystiGlam scaled to over AED 840,000 in a single month — entirely self-funded, in under two years. With the right capital, the right partner, and a clear four-year roadmap to AED 24–26M in annual revenue, the next chapter looks considerably bigger.
Launched November 2024. Scaled to AED 840K in a single month by March 2026 — bootstrapped, profitable, zero external funding.
Real COGS from Shopify product export. Average COGS 35.8% across 1,050 SKUs — delivering 64.2% gross margin, well above the 45–55% beauty retail benchmark.
MediCube and EQQUALBERRY are the primary revenue engines, with a strong supporting tier of established Korean skincare labels.
| # | Brand | Gross Sales | Orders | Avg Margin | Share |
|---|---|---|---|---|---|
| 1 | MediCube | AED 3,319,802 | 9,339 | 62.0% | 48.6% |
| 2 | EQQUALBERRY | AED 1,289,151 | 5,912 | 60.0% | 18.9% |
| 3 | celimax | AED 259,217 | 1,880 | 65.4% | 3.8% |
| 4 | Dr. Althea | AED 250,655 | 1,841 | 61.4% | 3.7% |
| 5 | La Roche Posay | AED 246,464 | 1,681 | 58.0% | 3.6% |
| 6 | Anua | AED 167,794 | 1,050 | 63.7% | 2.5% |
| 7 | Beauty of Joseon | AED 164,296 | 1,078 | 62.3% | 2.4% |
| 8 | Skin1004 | AED 147,746 | 988 | 65.2% | 2.2% |
| 9 | AXIS-Y | AED 146,817 | 1,273 | 67.6% | 2.1% |
| 10 | numbuzin | AED 134,512 | 723 | 61.1% | 2.0% |
| + 61 more brands across the full 1,050-SKU catalog | |||||
All products verified individually from Shopify product CSV. Real per-unit cost data across all 1,050 active SKUs.
| # | Product | Revenue | Units | Margin | Gross Profit |
|---|---|---|---|---|---|
| 1 | Medicube AGE-R Booster Pro Pink | AED 471,566 | 530 | 50.5% | AED 238,282 |
| 2 | medicube AGE-R Booster Pro Black | AED 338,574 | 364 | 60.0% | AED 203,015 |
| 3 | EQQUALBERRY Vitamin C Serum 30mL | AED 305,701 | 2,823 | 64.7% | AED 197,807 |
| 4 | EQQUALBERRY NAD+ Peptide Serum 30mL | AED 289,192 | 2,532 | 65.5% | AED 189,554 |
| 5 | medicube Collagen Night Wrapping Mask | AED 248,361 | 2,129 | 61.6% | AED 153,031 |
| 6 | medicube Deep Vita C Capsule Cream 55g | AED 217,293 | 1,705 | 62.6% | AED 136,029 |
| 7 | EQQUALBERRY Vitamin C Trio Set | AED 167,952 | 562 | 56.2% | AED 94,396 |
| 8 | celimax Retinal Shot Booster 15mL | AED 164,961 | 1,777 | 69.7% | AED 114,973 |
| 9 | EQQUALBERRY Bakuchiol Serum 30mL | AED 160,578 | 1,527 | 61.5% | AED 98,704 |
| 10 | Dr.Althea 345 Relief Cream 50mL | AED 157,278 | 1,566 | 60.6% | AED 95,320 |
| + 20 more verified top-30 products, 1,020 additional active SKUs | |||||
All 1,050 active SKUs analyzed. Zero products below 30% margin. 77% of catalog above 60%.
19,241 unique customers. Repeat rate grew from 0% at launch to 23% by May 2026.
COD declined from 84% at launch to 38% as store trust matured — a strong signal of brand credibility.
Store CVR reached an all-time high of 1.71% in June 2026. At March 2026 traffic with current CVR, that's 3,230+ orders and AED 827K+ monthly revenue.
Total lifetime discounts AED 213,566 — just 3.14% of gross sales. Strong improvement trend: from 10%+ early to consistently below 2% from Feb 2026.
1.07% lifetime return rate vs 5–8% industry average — protecting AED 270K+ per year and signalling strong product-description accuracy.
Strong presence across all 7 emirates. Dubai leads at 39.2%. Abu Dhabi at 14.6% represents a significant growth opportunity — comparable population, room to double.
Highly predictable purchase behaviour. Golden window: Friday–Sunday 9AM–3PM = 40% of weekly revenue.
Lifetime AOV AED 320. Peak AED 382 in Jul 2025. Current Jun 2026 at AED 256 — opportunity to recover via bundles and cross-sells.
Social media was the primary driver — 50.1% of all orders and 46.9% of lifetime revenue. Google Search/Shopping at 10.1%.
Proven unit economics, a loyal growing customer base, and clear paths to scale.